AxioMed Gains CE Mark Approval

AxioMed received approval under the CE Mark for their viscoelastic cervical disc device. Full global launch will occur within 2019.

Last month, parent company KICVentures announced that it seeks funding to prepare its spine portfolio companies, AxioMed and NanoFUSE Biologics, to be acquisition targets in the next...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0